000			02112nam a2200253Ia 4500
999			_c37382 _d37382
001			37382
003			DR-UNIBE
005			20201017115148.0
008			201017b2006 -us||||| |||| 00| 0 eng d
040			_cBIBLIOTECA UNIBE _aBIBLIOTECA UNIBE
041			_aeng
090			_aF- 3051
245	0		_aManaging cardiometabolic risk : an evolving approach to patient care : identify, understand, recognize, manage / _ceditor Karol Watson.
260	4		_aBoston : _bSanofi Aventis, _c2006
300	4		_a24 p. : ill. ; 28 cm.
504	4		_aIncludes bibliographical references (p. 23-24)
520	4		_aCardiometabolic risk encompasses a cluster of risk factors that may predispose individuals to cardiovascular disease and type 2 diabetes. These risk factors, some of which are currently undermanaged in clinical practice, involve multiple pathways and physiologic systems and point to a need for a comprehensive management approach. Abdominal obesity is a key component of cardiometabolic risk, increasing the incidence of insulin resistance, vascular inflammation, dyslipidemia, and hypertension. Adipose tissue, now recognized as an endocrine organ, and its hormonal products appear to play a significant role in the regulation of fat and glucose metabolism throughout the body. These mechanisms are clearly involved in the development of cardiovascular and metabolic disease. Current treatment protocols generally involve a fragmented approach to care, advocating management of only the clinically evident conditions. As cardiometabolic risk factors tend to cluster, patients often have additional subclinical conditions that would be discovered through comprehensive evaluation for the entire constellation of risk factors, thereby enabling clinicians to recommend optimal treatment to prevent cardiovascular and metabolic morbidities
650			_aSíndrome Metabólico _990989
650			_aSistema Cardiovascular _z-Enfermedades _z-Factores de riesgo _990990
650			_aEnfermedades cardiovasculares _990991
650			_aFactor de riesgo _990992
700	4	0	_aWatson, Karol. _990993
942			_aMX _2ddc